Sisram Medical Ltd. has announced a new Commercial Distribution Co-operation Agreement with Fosun Wanbang (Jiangsu) as of September 22, 2025. Under this agreement, Sisram Tianjin will handle the commercialization, marketing promotion, medical education, and commercialization planning of a specified product in the designated territory. Fosun Wanbang (Jiangsu) will be responsible for the import, procurement, customs clearance, legal inspection, warehousing, transportation, commercial channel distribution, and general distribution of the product. This collaboration aims to streamline the distribution and commercialization processes within the designated territory.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sisram Medical Ltd. published the original content used to generate this news brief on September 22, 2025, and is solely responsible for the information contained therein.